Related references
Note: Only part of the references are listed.The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid
Laura S. Hiemcke-Jiwa et al.
HEMATOLOGICAL ONCOLOGY (2018)
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities
Laura S. Hiemcke-Jiwa et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma
Keiichiro Hattori et al.
CANCER SCIENCE (2018)
Non-invasive detection of somatic mutations using nextgeneration sequencing in primary central nervous system lymphoma
Maxime Fontanilles et al.
ONCOTARGET (2017)
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy et al.
BLOOD (2016)
Characteristics and outcome of patients with primary CNS lymphoma in a real-life setting compared to a clinical trial
Vanja Zeremski et al.
ANNALS OF HEMATOLOGY (2016)
Frameless image-guided stereotactic brain biopsies: emphasis on diagnostic yield
Sodaba Khatab et al.
ACTA NEUROCHIRURGICA (2014)
Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma
Manuel Montesinos-Rongen et al.
ACTA NEUROPATHOLOGICA (2011)
Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry
Sandra Quijano et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Share Paper
